Keeping cartilage cells healthy to improve cartilage repair
Preserving chromatin nano-structure to enhance chondrocyte therapeutic potential for cartilage repair
This project looks for ways to preserve the tiny internal structure of cartilage cells so cells used for cartilage repair work better for people with joint cartilage damage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11160544 on NIH RePORTER |
What this research studies
Researchers will grow individual cartilage cells in the lab and use powerful imaging and single-cell gene-reading tools to see which cells still make the proteins that build cartilage. They will map tiny chromatin structures inside each cell and link those patterns to how well the cells produce cartilage matrix. The team will try different chemical and physical conditions to keep or restore cells into a repair-ready state and use machine learning to predict which cells will be most effective. The work aims to create lab methods that yield higher-quality cells for future cartilage-repair therapies.
Who could benefit from this research
Good fit: Ideal candidates would be people with focal cartilage defects or joint injuries who might someday be eligible for cell-based cartilage repair procedures.
Not a fit: People with widespread, end-stage osteoarthritis or conditions unrelated to cartilage damage are unlikely to benefit directly from this lab-focused work.
Why it matters
Potential benefit: If successful, this work could lead to lab-grown cartilage cells that produce stronger, longer-lasting repair tissue for people with cartilage injuries.
How similar studies have performed: Previous efforts to improve cell expansion for cartilage repair have had limited success, and combining chromatin nano-structure mapping with machine-learning prediction for chondrocyte therapy is a relatively new approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Heo, Su Chin — University of Pennsylvania
- Study coordinator: Heo, Su Chin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.